Search





Search





Cardiol Therapeutics Inc

CRDL

Add to Watchlist

1.730USD

-0.040-2.26%

Close 09-23 16:00（ET）

199.37MMarket Cap

LossP/E TTM

After-hours 18:57 (ET)1.740USD+0.005+0.29%

Cardiol Therapeutics Inc

1.730

-0.040-2.26%

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

CRDL Cash Flow Statement

You can access the annual and quarterly cash flow statements of Cardiol Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q2

FY2018Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

4.62%-3.14M

-7.43%-5.50M

3.40%-3.76M

10.71%-4.94M

5.23%-3.29M

-0.86%-5.12M

18.40%-3.89M

-121.62%-5.53M

12.73%-3.48M

31.33%-5.07M

27.38%-4.76M

32.20%-2.49M

-16.28%-3.98M

-5.10%-7.39M

-105.60%-6.56M

27.94%-3.68M

29.10%-3.42M

-19.71%-7.03M

-54.78%-3.19M

-124.84%-5.10M

-439.01%-4.83M

-240.79%-5.87M

5.51%-2.06M

-42.52%-2.27M

45.14%-896.24K

42.74%-1.72M

65.26%-2.18M

---1.59M

-298.83%-1.63M

-1045.12%-3.01M

---6.28M

---409.64K

---262.74K

Net income from continuing operations

27.84%-4.36M

-33.45%-7.91M

8.81%-5.18M

21.58%-7.10M

-26.07%-6.05M

11.88%-5.93M

-1.00%-5.68M

-109.07%-9.05M

13.69%-4.80M

-27.76%-6.73M

-1.84%-5.63M

27.64%-4.33M

-9.38%-5.56M

24.48%-5.27M

-10.92%-5.53M

24.43%-5.99M

2.65%-5.08M

5.58%-6.97M

35.27%-4.98M

-136.47%-7.92M

-90.35%-5.22M

-253.08%-7.38M

-252.72%-7.70M

-26.93%-3.35M

0.49%-2.74M

19.26%-2.09M

67.68%-2.18M

---2.64M

-166.33%-2.76M

-505.31%-2.59M

---6.75M

---1.03M

---427.92K

Operating gains losses

-55.07%8.28K

9.28%19.53K

-44.61%18.67K

-87.27%18.21K

-59.08%18.44K

-60.42%17.87K

-31.49%33.71K

201.83%143.05K

3.55%45.05K

4.46%45.15K

15.28%49.20K

15.87%47.39K

3.33%43.51K

3.54%43.23K

-3.58%42.68K

-7.94%40.90K

-3.09%42.10K

-7.77%41.75K

-4.80%44.26K

1.80%44.43K

-0.02%43.45K

13.25%45.27K

29.95%46.50K

46.14%43.65K

53.26%43.46K

130.00%39.97K

104.73%35.78K

--29.87K

65.82%28.35K

-0.22%17.38K

--17.48K

--17.10K

--17.42K

Other non-cash items

-155.31%-224.63K

-310.52%-162.27K

133.81%376.92K

-204.29%-263.13K

472.80%406.09K

121.42%77.08K

-71.72%-1.11M

-64.32%252.30K

82.70%-108.93K

-3639.69%-359.86K

68.79%-649.24K

335.18%707.13K

-213.37%-629.62K

-98.49%10.17K

-330.83%-2.08M

-89.69%162.49K

61.86%555.39K

22.78%672.46K

2460.18%901.06K

6427.06%1.58M

--343.13K

1363.27%547.72K

-90.06%35.20K

--24.15K

--0.00

--37.43K

943.04%354.24K

----

--33.96K

----

Change in working capital

14.70%557.37K

180.20%87.09K

-165.85%-453.30K

76.68%-443.38K

-14.62%485.93K

-377.56%-108.59K

-39.28%688.41K

-1336.19%-1.90M

-44.58%569.13K

99.07%-22.74K

-20.46%1.13M

-118.70%-132.40K

-53.04%1.03M

-4358.43%-2.44M

29.03%1.43M

60.41%708.07K

431.86%2.19M

106.68%57.27K

-79.12%1.10M

-17.76%441.41K

-166.60%-658.93K

-252.98%-857.57K

751.10%5.29M

-10.07%536.73K

127.74%989.33K

82.26%-242.95K

82.32%-812.73K

--596.85K

-19.65%434.41K

-1115.80%-1.37M

---4.60M

--540.67K

--134.81K

-Change in receivables

-59.80%19.44K

-877.19%-82.99K

66.98%-21.79K

446.58%59.87K

-11.04%48.35K

139.14%10.68K

-1020.69%-65.97K

-252.85%-17.27K

-29.12%54.35K

-151.00%-27.28K

134.65%7.17K

131.06%11.30K

18.89%76.68K

187.11%53.50K

-19.40%-20.68K

-115.23%-36.38K

122.04%64.49K

23.12%-61.41K

-134.76%-17.32K

395.15%238.84K

-142.20%-292.61K

31.73%-79.89K

120.69%49.82K

22.45%-80.92K

1348053.44%693.40K

-1961.65%-117.01K

-4021.74%-240.84K

---104.35K

100.13%51.43

47.21%6.29K

--6.14K

---39.84K

--4.27K

-Change in inventory

----

--0.00

----

-100.00%0.00

100.00%0.00

-92.08%14.29K

100.00%0.00

-17.97%738.32K

-114.75%-13.87K

-83.92%180.43K

98.36%-33.13K

--900.09K

--93.99K

--1.12M

---2.02M

----

--0.00

-Change in prepaid expenses

25.05%302.05K

-57.42%-1.02M

-323.06%-625.58K

-36.20%221.43K

157.10%241.54K

-9.84%-648.30K

-43.90%280.45K

316.22%347.06K

-84.83%93.95K

-6.70%-590.24K

138.07%499.95K

-121.64%-160.51K

22.96%619.35K

-24.49%-553.18K

128.31%210.00K

52.23%741.89K

198.76%503.69K

54.72%-444.36K

-118.61%-741.81K

320.14%487.33K

-96.42%-510.02K

-930.68%-981.44K

549.41%3.99M

69.85%115.99K

60.13%-259.66K

-105.78%-95.22K

82.22%-887.04K

--68.29K

-1541.31%-651.21K

18943.35%1.65M

---4.99M

---39.68K

--8.65K

-Change in payables and accrued expense

20.33%235.88K

125.05%1.19M

-59.05%194.06K

67.52%-724.68K

-53.42%196.03K

-11.06%529.03K

-24.37%473.93K

-13374.46%-2.23M

27.17%420.83K

130.67%594.79K

-49.31%626.63K

557.07%16.81K

-79.55%330.93K

-444.38%-1.94M

-33.68%1.24M

100.90%2.56K

1150.84%1.62M

176.32%563.04K

260.39%1.86M

-155.24%-284.76K

-65.51%129.40K

8349.59%203.76K

188.42%517.17K

-4.34%515.53K

315.74%375.16K

100.28%2.41K

-218.56%-584.93K

--538.91K

-128.45%-173.89K

-759.35%-864.15K

--493.35K

--611.19K

--131.06K

-Change in other current assets

----

1430.47%137.72K

-1374.07%-135.10K

---106.21K

--9.00K

---9.17K

Cash from non-recurring investing activities

Cash from operating activities

4.62%-3.14M

-7.43%-5.50M

3.40%-3.76M

10.71%-4.94M

5.23%-3.29M

-0.86%-5.12M

18.40%-3.89M

-121.62%-5.53M

12.73%-3.48M

31.33%-5.07M

27.38%-4.76M

32.20%-2.49M

-16.28%-3.98M

-5.10%-7.39M

-105.60%-6.56M

27.94%-3.68M

29.10%-3.42M

-19.71%-7.03M

-54.78%-3.19M

-124.84%-5.10M

-439.01%-4.83M

-240.79%-5.87M

5.51%-2.06M

-42.52%-2.27M

45.14%-896.24K

42.74%-1.72M

65.26%-2.18M

---1.59M

-298.83%-1.63M

-1045.12%-3.01M

---6.28M

---409.64K

---262.74K

Investing cash flow

Net cash from continuing investing activities

-53.37%2.17K

307.46%34.79K

-48.16%2.22K

-61.59%2.15K

68.53%4.66K

236.79%8.54K

-45.74%4.28K

37.47%5.60K

-4.44%2.77K

-92.27%2.54K

-77.57%7.89K

-41.59%4.07K

73.71%2.89K

172.26%32.78K

--35.17K

-32.45%6.97K

--1.67K

--12.04K

-100.00%0.00

93.72%10.32K

-100.00%0.00

-80.67%10.75K

-97.01%5.33K

-97.99%1.55K

107.12%12.80K

1370.55%55.60K

--178.18K

--77.38K

--6.18K

--3.78K

--0.00

Capital expenditures

-53.37%2.17K

307.46%34.79K

-48.16%2.22K

-61.59%2.15K

68.53%4.66K

236.79%8.54K

-45.74%4.28K

37.47%5.60K

-4.44%2.77K

-92.27%2.54K

-77.57%7.89K

-41.59%4.07K

73.71%2.89K

172.26%32.78K

--35.17K

-32.45%6.97K

--1.67K

--12.04K

-100.00%0.00

93.72%10.32K

-100.00%0.00

-80.67%10.75K

-97.01%5.33K

-97.99%1.55K

107.12%12.80K

1370.55%55.60K

--178.18K

--77.38K

--6.18K

--3.78K

--0.00

Net cash flow from disposal of fixed assets

-53.37%2.17K

307.46%34.79K

-48.16%2.22K

-61.59%2.15K

68.53%4.66K

236.79%8.54K

-45.74%4.28K

37.47%5.60K

-4.44%2.77K

-92.27%2.54K

-77.57%7.89K

-41.59%4.07K

73.71%2.89K

172.26%32.78K

--35.17K

-32.45%6.97K

--1.67K

--12.04K

-100.00%0.00

93.72%10.32K

-100.00%0.00

-80.67%10.75K

-97.01%5.33K

-97.99%1.55K

107.12%12.80K

1370.55%55.60K

--178.18K

--77.38K

--6.18K

--3.78K

--0.00

Net cash flow from intangible asset transactions

----

--0.00

----

Net cash flow from other investing activities

----

--0.00

----

---44.27K

----

Cash from non-current investing activities

Net cash flow from investing activities

53.37%-2.17K

-307.46%-34.79K

48.16%-2.22K

61.59%-2.15K

-68.53%-4.66K

-236.79%-8.54K

45.74%-4.28K

-37.47%-5.60K

4.44%-2.77K

92.27%-2.54K

77.57%-7.89K

41.59%-4.07K

-73.71%-2.89K

-172.26%-32.78K

---35.17K

32.45%-6.97K

---1.67K

---12.04K

100.00%0.00

-93.72%-10.32K

100.00%0.00

80.67%-10.75K

97.01%-5.33K

97.99%-1.55K

-107.12%-12.80K

-1370.55%-55.60K

---178.18K

-74.80%-77.38K

---6.18K

---3.78K

---44.27K

--0.00

Financing cash flow

Cash flow from continuous financing activities

11925.46%1.78M

100526.61%9.94M

-13.99%11.17M

-200.51%-9.87K

-74.00%14.78K

-117.70%-9.90K

127431.92%12.99M

67.53%-3.28K

651.88%56.83K

644.17%55.95K

-0.21%-10.20K

2.73%-10.11K

0.87%-10.30K

-1.74%-10.28K

-100.02%-10.18K

-100.56%-10.39K

-100.06%-10.39K

-100.11%-10.11K

73046.47%47.18M

2295.76%1.86M

35.58%16.54M

106810.88%9.17M

846.35%64.50K

1374.53%77.80K

3714.72%12.20M

-100.71%-8.59K

-100.09%-8.64K

---6.10K

-95.70%319.72K

--1.21M

--10.05M

--7.43M

--0.00

Net cash flow from debt Issuance/repayment

0.88%-9.93K

-2.23%-10.12K

-3.40%-9.95K

-200.51%-9.87K

-49.19%-10.02K

2.40%-9.90K

5.69%-9.62K

67.53%-3.28K

34.77%-6.72K

1.33%-10.14K

-0.21%-10.20K

2.73%-10.11K

0.87%-10.30K

-1.74%-10.28K

1.49%-10.18K

-0.20%-10.39K

-0.61%-10.39K

6.05%-10.11K

-0.01%-10.33K

-5.02%-10.37K

-10.05%-10.32K

-25.19%-10.76K

-19.57%-10.33K

-61.84%-9.88K

---9.38K

---8.59K

---8.64K

---6.10K

----

--0.00

--7.43M

----

Net cash flow from common stock issuance/repurchase

--0.00

--10.86M

-22.35%11.53M

----

--14.84M

----

-100.00%0.00

--0.00

----

--49.43M

--0.00

34.13%17.50M

----

--0.00

42434.90%13.05M

-100.00%0.00

--0.00

--30.68K

--1.21M

--10.59M

--0.00

Proceeds from stock option exercised by employees

-100.00%0.00

----

--0.00

-60.97%24.80K

-100.00%0.00

--0.00

--63.54K

--66.09K

----

--0.00

-100.00%0.00

--0.00

--102.98K

--82.41K

--2.16M

----

--0.00

----

--0.00

----

Proceeds from issuance of warrants

--1.79M

----

-100.00%0.00

1016.18%835.29K

2494.38%1.77M

--58.18K

--7.02M

--74.84K

--68.27K

-100.00%0.00

----

--0.00

--289.05K

----

--0.00

----

Net cash flow from other financing activities

--0.00

---903.98K

81.40%-342.84K

--0.00

----

---1.84M

----

100.00%0.00

--0.00

----

---3.08M

-100.00%0.00

-30.13%-1.10M

----

--0.00

--19.40K

---842.42K

----

--0.00

----

---538.66K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

11925.46%1.78M

100526.61%9.94M

-13.99%11.17M

-200.51%-9.87K

-74.00%14.78K

-117.70%-9.90K

127431.92%12.99M

67.53%-3.28K

651.88%56.83K

644.17%55.95K

-0.21%-10.20K

2.73%-10.11K

0.87%-10.30K

-1.74%-10.28K

-100.02%-10.18K

-100.56%-10.39K

-100.06%-10.39K

-100.11%-10.11K

73046.47%47.18M

2295.76%1.86M

35.58%16.54M

106810.88%9.17M

846.35%64.50K

1374.53%77.80K

3714.72%12.20M

-100.71%-8.59K

-100.09%-8.64K

---6.10K

-95.70%319.72K

--1.21M

--10.05M

--7.43M

--0.00

Net cash flow

Beginning cash balance

17.76%19.85M

-28.40%15.66M

-24.35%8.35M

-24.12%12.97M

-18.92%16.86M

-14.56%21.87M

-63.04%11.04M

-47.94%17.09M

-43.48%20.79M

-42.04%25.60M

-38.01%29.88M

-37.95%32.82M

-37.21%36.79M

-32.39%44.17M

111.24%48.19M

102.28%52.90M

309.17%58.60M

462.01%65.33M

73.15%22.81M

76.81%26.15M

320.99%14.32M

135.59%11.62M

82.77%13.18M

57.12%14.79M

-68.54%3.40M

-60.26%4.93M

-16.96%7.21M

--9.41M

603.56%10.81M

579.14%12.41M

--8.68M

--1.54M

--1.83M

Current period cash flow changes

69.04%-1.14M

187.77%4.57M

-31.08%7.04M

19.07%-4.68M

-11.39%-3.69M

-11.86%-5.21M

347.12%10.21M

-80.02%-5.79M

1.59%-3.31M

37.27%-4.66M

7.29%-4.13M

13.00%-3.22M

2.06%-3.37M

-5.35%-7.43M

-110.14%-4.46M

-13.68%-3.70M

-129.36%-3.44M

-313.82%-7.05M

2290.94%43.99M

-47.92%-3.25M

3.59%11.70M

289.05%3.30M

10.60%-2.01M

-23.66%-2.20M

912.02%11.30M

3.52%-1.74M

-159.56%-2.25M

---1.78M

-119.94%-1.39M

-588.10%-1.81M

--3.77M

--6.98M

---262.74K

Effect of exchange rate changes

155.31%224.63K

310.52%162.27K

-133.81%-376.92K

204.29%263.13K

-472.80%-406.09K

-121.42%-77.08K

71.72%1.11M

64.32%-252.30K

-82.70%108.93K

17456.07%359.86K

-69.76%649.24K

---707.13K

--629.62K

--2.05K

--2.15M

----

Ending cash balance

42.08%18.71M

21.46%20.23M

-27.58%15.39M

-26.70%8.28M

-24.67%13.17M

-20.43%16.66M

-17.44%21.26M

-61.83%11.30M

-47.70%17.48M

-43.01%20.94M

-41.14%25.74M

-39.83%29.61M

-39.40%33.43M

-36.96%36.74M

-34.53%43.73M

114.86%49.21M

111.94%55.16M

290.56%58.28M

498.16%66.80M

81.85%22.90M

77.04%26.03M

367.81%14.92M

125.03%11.17M

64.91%12.59M

56.04%14.70M

-69.93%3.19M

-60.14%4.96M

--7.64M

10.65%9.42M

577.63%10.61M

--12.45M

--8.51M

--1.57M

Free cash flow

4.68%-3.14M

-7.93%-5.53M

3.45%-3.76M

10.76%-4.94M

5.17%-3.30M

-0.98%-5.12M

18.44%-3.89M

-121.48%-5.53M

12.72%-3.48M

31.60%-5.08M

27.64%-4.77M

32.21%-2.50M

-16.31%-3.99M

-5.39%-7.42M

-106.70%-6.60M

27.95%-3.68M

29.07%-3.43M

-19.92%-7.04M

-53.98%-3.19M

-124.77%-5.11M

-438.08%-4.83M

-238.28%-5.87M

7.38%-2.07M

-28.48%-2.28M

47.53%-897.80K

42.43%-1.74M

64.39%-2.24M

---1.77M

-317.72%-1.71M

-1047.47%-3.01M

---6.28M

---409.64K

---262.74K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Cardiol Therapeutics Inc Generate?



Cardiol Therapeutics Inc generated -17.14M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Cardiol Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Cardiol Therapeutics Inc's operating cash flow increased by 1.58% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Cardiol Therapeutics Inc Spend on Capital Expenditures?



Cardiol Therapeutics Inc spent 17.60K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Cardiol Therapeutics Inc's Financing Cash Flow Changed?



Cardiol Therapeutics Inc used 11.17M in financing activities in the latest quarter.

What is free cash flow and why does it matter for CRDL?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Cardiol Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -17.16M reflecting a 1.56% change from the previous year.